PER 1.01% 10.0¢ percheron therapeutics limited

trading halt, page-128

  1. 3,335 Posts.
    lightbulb Created with Sketch. 165
    Use your head and read when the conclusion of trials and report was previously advised. We are now looking at a further 4 months, in addition there was the unwarranted run on the shares just prior to the likely announcement. They obviously were awaiting either approval from one or more directors or our partner ISIS.
    Without the trading halt the shares would most likely ended up at 1.4c or less, thus burning some shareholders unnecessarily.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.